|
|
Committees
International Organising Committee
Chairman
| Assoc. Prof. Marko ANDERLUH (University of Ljubljana, Ljubljana, Slovenia) |
Members
| Dr Yves P. AUBERSON (Novartis Institutes for BioMedical Research, Basel, Switzerland) |
| Prof. Roberto DI SANTO (Sapienza University of Rome, Rome, Italy) |
| Dr Phil JONES (University of Dundee, Lanarkshire, United Kingdom) |
| Dr Jürgen MACK (Boehringer Ingelheim, Biberach an der Riss, Germany) |
| Prof. Hans Ulrich STILZ (Novo Nordisk, Malov, Denmark) |
| Dr Cornelia ZUMBRUNN (Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland) |
Local Organising Committee
Members
| Prof. Gregor ANDERLUH (National Institute of Chemistry, Ljubljana, Slovenia) |
| Assoc. Prof. Marko ANDERLUH (University of Ljubljana, Ljubljana, Slovenia) |
| Assoc. Prof. Janez ILAS (University of Ljubljana, Ljubljana, Slovenia) |
| Dr Ziga JAKOPIN (University of Ljubljana, Ljubljana, Slovenia) |
| Dr Simona JEVSEVAR (Lek d.d., Ljubljana, Slovenia) |
| Prof. Danijel KIKELJ (University of Ljubljana, Ljubljana, Slovenia) |
| Dr Gregor KOSEC (Acies Bio, Ljubljana, Slovenia) |
| Dr Gašper MARC (F. Hoffmann-La Roche, Ljubljana, Slovenia) |
| Assoc. Prof. Lucija PETERLIN MASIC (University of Ljubljana, Ljubljana, Slovenia) |
| Prof. Jurij SVETE (University of Ljubljana, Ljubljana, Slovenia) |
International Scientific Committee
Members
| Prof. Sergei Olegovich BACHURIN (Institute of Physiologically Active Compounds, Chernogolovka, Russia) |
| Prof. Eliezer BARREIRO (Federal University of Rio de Janeiro, Rio de Janeiro, Brazil) |
| Dr Jonathan BENNETT (Merck, Sharp & Dohme, Boston, United States) |
| Dr Hayley BINCH (F. Hoffmann-La Roche Ltd, Basel, Switzerland) |
| Dr Mark BUNNAGE (Vertex Pharmaceuticals, Boston, United States) |
| Dr Nicholas CARRUTHERS (Johnson & Johnson R&D, San Diego, United States) |
| Prof. Kelly CHIBALE (University of Cape Town, Cape Town, South Africa) |
| Dr Ian CHURCHER (BenevolentAI, London, United Kingdom) |
| Prof. Gabriele COSTANTINO (University of Parma, Parma, Italy) |
| Prof. Flavio DA SILVA EMERY (University of Sao Paulo, Ribeirão Preto, Brazil) |
| Prof. Benoit DEPREZ (University of Lille 2, Lille, France) |
| Dr Daniele DONATI (Nerviano Medical Sciences, Nerviano, Italy) |
| Prof. Marcin DRAG (WROCLAV UNIVERSITY OF TECHNOLOGY, Wroclaw, Poland) |
| Dr Antony GEE (King's College London, London, United Kingdom) |
| Prof. Stanislav GOBEC (University of Ljubljana, Ljubljana, Slovenia) |
| Prof. Maria Pilar GOYA LAZA (Instituto de Quimica Medic, CSIC, Madrid, Spain) |
| Dr Renate GRIFFITH (University of New South Wales, UNSW Sydney, Australia) |
| Dr Adrian HALL (UCB Pharma S.A., Braine-l'Alleud, Belgium) |
| Dr Gregory HOLLINGWORTH (Novartis Pharma Schweiz AG, Rotkreuz, Switzerland) |
| Dr Bayard HUCK (Merck Biopharma, Darmstadt, Germany) |
| Prof. Ad P. IJZERMAN (University of Leiden, Leiden, The Netherlands) |
| Dr Rolf JAUTELAT (Bayer, Wuppertal, Germany) |
| Dr Allan JORDAN (Cancer Research UK Manchester Institute, Manchester, United Kingdom) |
| Prof. Ivars KALVINS (Latvian Institute of Organic Synthesis, Riga, Latvia) |
| Prof. Gyorgy KESERU (Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary) |
| Prof. Stefan LAUFER (University Tübingen, Tübingen, Germany) |
| Dr Malin LEMURELL (AstraZeneca, Mölndal, Sweden) |
| Dr John E. MACOR (Sanofi, Waltham, United States) |
| Prof. Matilde MARQUES (Instituto Superior Técnico, Lisboa, Portugal) |
| Dr Lieven MEERPOEL (Janssen R&D, Beerse, Belgium) |
| Dr Fabrizio MICHELI (Aptuit, Verona, Italy) |
| Dr Christian MONTALBETTI (Inventiva, Daix, France) |
| Prof. Dario NERI (ETH Zürich, Zürich, Switzerland) |
| Prof. Ulf NILSSON (LUND UNIVERSITY, Lund, Sweden) |
| Dr Daniel OBRECHT (Polyphor, Allschwil, Switzerland) |
| Dr Thorsten OOST (Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany) |
| Mrs Leena OTSOMAA (Orion Corporation Orion Pharma, Espoo, Finland) |
| Prof. Roberto PELLICCIARI (TES Pharma, Perugia, Italy) |
| Dr Ivo PIANTANIDA (Rudjer Boskovic Institute, Zagreb, Croatia) |
| Dr Paul RATCLIFFE (Grünenthal, Aachen, Germany) |
| Dr David REES (Astex Pharmaceuticals, Cambridge, United Kingdom) |
| Dr Didier ROCHE (EDELRIS, Lyon, France) |
| Prof. Leonardo SCAPOZZA (University of geneva, Genève 4, Switzerland) |
| Prof Bogdan SOLAJA (Faculty of Chemistry, Universiy of Belgrade, Belgrade, Serbia and Montenegro) |
| Prof. Jan STEYAERT (VUB, Brussels, Belgium) |
| Dr Vincenzo SUMMA (IRBM - MRL, Pomezia, Italy) |
| Prof. Giulio SUPERTI-FURGA (Research Center for Molecular Medicine (CEMM), Vienna, Austria) |
| Prof. Edward TATE (Imperial College London, London, United Kingdom) |
| Dr Atli THORARENSEN (Pfizer, New-York, United States) |
| Prof. Henk TIMMERMAN (VU University Amsterdam, Amsterdam, The Netherlands) |
| Prof. Nicholas John TURNER (University of Manchester, Manchester, United Kingdom) |
| Dr Klaus URBAHNS (Merck KGaA, Darmstadt, Germany) |
| Dr Luc VAN HIJFTE (SCT & Novithera, Illkirch, France) |
| Dr Franz VON NUSSBAUM (Bayer SAS, Lyon, France) |
| Prof. Herbert WALDMANN (Max Planck Institute of Molecular Physiology, Dortmund, Germany) |
| Dr Mingqiang ZHANG (Amgen, Shanghai City, China) |
| Prof. Grigorios ZOIDIS (EKPA - ELKE, Athens, Greece) |
|
|
